A detailed history of Usa Financial Portformulas Corp transactions in Astrazeneca PLC stock. As of the latest transaction made, Usa Financial Portformulas Corp holds 16,554 shares of AZN stock, worth $1.1 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
16,554
Holding current value
$1.1 Million
% of portfolio
0.2%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$76.67 - $87.62 $1.27 Million - $1.45 Million
16,554 New
16,554 $1.29 Million
Q3 2023

Nov 27, 2023

SELL
$64.85 - $71.7 $712,052 - $787,266
-10,980 Reduced 98.49%
168 $11,000
Q2 2023

Nov 27, 2023

SELL
$69.91 - $75.81 $2.13 Million - $2.3 Million
-30,400 Reduced 73.17%
11,148 $797,000
Q3 2022

Oct 24, 2022

SELL
$53.02 - $135.75 $46,074 - $117,966
-869 Reduced 2.05%
41,548 $2.28 Million
Q2 2022

Aug 15, 2022

BUY
$59.26 - $71.14 $2.51 Million - $3.02 Million
42,417 New
42,417 $2.8 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $205B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Usa Financial Portformulas Corp Portfolio

Follow Usa Financial Portformulas Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Usa Financial Portformulas Corp, based on Form 13F filings with the SEC.

News

Stay updated on Usa Financial Portformulas Corp with notifications on news.